Delivery Order SPE2DB24D3015-SPE2DB24FFXKH

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $2,559.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 140 MG/ML autoinjectors, with a completion date of May 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025, which serves as...
The Defense Logistics Agency (DLA) awarded a $1,651.83 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division to provide AIMOVIG 140 MG/ML autoinjectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,895.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 1, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, to provide AIMOVIG 140 mg/mL autoinjectors. The $1,357.86 firm-fixed-price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $3,457.38 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceuticals to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to...
The Defense Logistics Agency (DLA) awarded a $3,615.28 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of AIMOVIG 70 MG/ML AUTOINJECTORML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $8,761.90 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of AIMOVIG 70 MG/ML autoinjectors, with a period of performance ending on August 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which allows the...
The Defense Logistics Agency (DLA) awarded a $1,264.14 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTOR medications. The delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,558.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a $3,620.96 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medication. The order has a firm fixed price and an ultimate completion date of August 23, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFXKH
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $3,125.09 firm-fixed price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML autoinjectors. The order has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/21/24, 9:40 AM